.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Fish and Richardson
Deloitte
Cipla
Baxter
AstraZeneca
Healthtrust
Federal Trade Commission
UBS
Fuji

Generated: September 25, 2017

DrugPatentWatch Database Preview

Meropenem - Generic Drug Details

« Back to Dashboard

What are the generic sources for meropenem and what is the scope of meropenem freedom to operate?

Meropenem
is the generic ingredient in four branded drugs marketed by Sandoz, Acs Dobfar, Pfizer, B Braun Medical Inc, Aurobindo Pharma Ltd, Par Sterile Products, Hospira Inc, Gland Pharma Ltd, Daewoong Pharm Co, Amneal Pharms, Savior Lifetec Corp, and Rempex Pharms Medcns, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.

There are thirty-one drug master file entries for meropenem. Fourteen suppliers are listed for this compound.

Summary for Generic Name: meropenem

Tradenames:4
Patents:0
Applicants:12
NDAs:12
Drug Master File Entries: see list31
Suppliers / Packagers: see list14
Bulk Api Vendors: see list52
Clinical Trials: see list76
Patent Applications: see list5,384
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:meropenem at DailyMed

Pharmacology for Ingredient: meropenem

Ingredient-typeCarbapenems
Drug ClassPenem Antibacterial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION205835-002Mar 27, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
Acs Dobfar
MEROPENEM
meropenem
INJECTABLE;INJECTION091404-001Oct 26, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Par Sterile Products
MEROPENEM
meropenem
INJECTABLE;INJECTION204139-001Jun 9, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
B Braun Medical Inc
MEROPENEM AND SODIUM CHLORIDE IN DUPLEX CONTAINER
meropenem
POWDER;IV (INFUSION)202106-002Apr 30, 2015RXNoNo► Subscribe► Subscribe► Subscribe
Hospira Inc
MEROPENEM
meropenem
INJECTABLE;INJECTION090940-001Jun 22, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Gland Pharma Ltd
MEROPENEM
meropenem
INJECTABLE;INJECTION206141-002Jun 8, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Rempex Pharms Medcns
VABOMERE
meropenem; vaborbactam
POWDER;IV (INFUSION)209776-001Aug 29, 2017RXYesYes► Subscribe► Subscribe► Subscribe
Hospira Inc
MEROPENEM
meropenem
INJECTABLE;INJECTION090940-002Jun 22, 2010APRXNoNo► Subscribe► Subscribe► Subscribe
Daewoong Pharm Co
MEROPENEM
meropenem
INJECTABLE;INJECTION204854-002Dec 18, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
Daewoong Pharm Co
MEROPENEM
meropenem
INJECTABLE;INJECTION204854-001Dec 18, 2015APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: meropenem

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer
MERREM
meropenem
INJECTABLE;INJECTION050706-001Jun 21, 1996► Subscribe► Subscribe
Pfizer
MERREM
meropenem
INJECTABLE;INJECTION050706-003Jun 21, 1996► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Colorcon
US Army
Express Scripts
Baxter
Cantor Fitzgerald
Fish and Richardson
US Department of Justice
Medtronic
Cerilliant
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot